D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -75.45%516M | -73.46%2.1B | 510.09%7.92B | -84.77%1.3B | 113.96%8.52B | -28.80%3.98B | 1.01%5.59B | -1.84%5.54B | 7.69%5.64B | -28.46%5.24B |
Net profit before non-cash adjustment | -44.90%1.69B | -43.11%3.07B | 78.41%5.4B | 131.69%3.02B | -433.79%-9.54B | -46.33%2.86B | 115.06%5.33B | -29.23%2.48B | -12.67%3.5B | -32.63%4.01B |
Total adjustment of non-cash items | 142.74%50M | -128.33%-117M | -70.75%413M | -90.60%1.41B | 673.52%15.01B | -20.74%1.94B | -7.31%2.45B | 12.52%2.64B | 56.22%2.35B | 118.46%1.5B |
-Depreciation and amortization | 25.32%1.66B | 26.38%1.33B | 29.95%1.05B | -54.56%808M | -38.73%1.78B | -0.82%2.9B | 0.21%2.93B | -8.49%2.92B | 22.26%3.19B | 47.71%2.61B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | --51M | --0 | --13.52B | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | -133.33%-7M | 96.43%-3M | -162.50%-84M | -113.17%-32M | 132.88%243M | -370.70%-739M | -49.52%-157M | 76.46%-105M | -14.95%-446M | 34.90%-388M |
-Net exchange gains and losses | -45.34%-686M | -5.36%-472M | -144.81%-448M | -245.24%-183M | 250.00%126M | 157.14%36M | -86.67%14M | 216.67%105M | 67.97%-90M | 27.01%-281M |
-Other non-cash items | 5.06%-920M | -521.15%-969M | -119.05%-156M | 224.66%819M | -154.65%-657M | 22.75%-258M | -20.14%-334M | 9.45%-278M | 29.91%-307M | -346.94%-438M |
Changes in working capital | -44.52%-1.23B | -140.26%-849M | 167.27%2.11B | -202.82%-3.14B | 473.19%3.05B | 62.52%-817M | -624.04%-2.18B | 302.93%416M | 24.07%-205M | -139.30%-270M |
-Change in receivables | -940.72%-1.74B | -113.97%-167M | 224.87%1.2B | -138.43%-957M | 85.68%2.49B | 169.34%1.34B | -4,935.00%-1.93B | -93.15%40M | 187.03%584M | -148.94%-671M |
-Change in inventory | 161.84%329M | -1,050.00%-532M | 109.88%56M | -254.38%-567M | -3,100.00%-160M | 99.38%-5M | -297.56%-808M | 139.52%409M | -158.10%-1.04B | 12.64%-401M |
-Change in payables | -99.72%1M | -46.10%359M | 198.52%666M | -2,314.29%-676M | 98.59%-28M | -334.83%-1.98B | 2,444.44%844M | -115.45%-36M | -15.88%233M | 93.71%277M |
-Provision for loans, leases and other losses | 279.31%52M | -176.32%-29M | 280.95%38M | -231.25%-21M | 300.00%16M | -157.14%-8M | 16.67%14M | --12M | --0 | -400.00%-10M |
-Changes in other current assets | 126.88%129M | -411.69%-480M | 116.85%154M | -225.03%-914M | 548.47%731M | 44.93%-163M | -3,188.89%-296M | -169.23%-9M | -97.57%13M | 246.17%535M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 20.00%-4M | 54.55%-5M | 31.25%-11M | 11.11%-16M | 18.18%-18M | 18.52%-22M | 12.90%-27M | 13.89%-31M | -111.76%-36M | 19.05%-17M |
Interest received (cash flow from operating activities) | 29.88%526M | 1.50%405M | -15.64%399M | -13.84%473M | 24.21%549M | -0.23%442M | 17.20%443M | 4.71%378M | 7.44%361M | -11.11%336M |
Tax refund paid | 43.37%-525M | -486.71%-927M | 73.13%-158M | -53.93%-588M | 70.20%-382M | -93.07%-1.28B | 33.53%-664M | -169.27%-999M | 73.96%-371M | -11.85%-1.43B |
Other operating cash inflow (outflow) | 0 | -102.33%-1M | -52.22%43M | 9,100.00%90M | -1M | 0 | 0 | 0.00%-1M | 0.00%-1M | -1M |
Operating cash flow | -67.41%513M | -80.79%1.57B | 551.71%8.19B | -85.50%1.26B | 177.80%8.67B | -41.62%3.12B | 9.44%5.35B | -12.69%4.89B | 35.41%5.6B | -35.50%4.13B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -139.65%-4.49B | -1.90%-1.87B | 2.75%-1.84B | -13.37%-1.89B | -41.12%-1.67B | -7.45%-1.18B | -34.80%-1.1B | 61.03%-816M | -41.39%-2.09B | 81.38%-1.48B |
Net intangibles purchase and sale | 61.24%-69M | 15.64%-178M | -27.11%-211M | 45.75%-166M | -827.27%-306M | 87.82%-33M | -0.74%-271M | -40.10%-269M | -433.33%-192M | 68.14%-36M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---3.13B | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | -148.63%-2.65B | 87.52%5.45B | -5.12%2.91B | -46.46%3.07B | 2,276.81%5.73B | 90.24%-263M | -9.91%-2.69B | -109.67%-2.45B | 34.21%-1.17B | -137.28%-1.78B |
Net changes in other investments | 108.33%3M | -400.00%-36M | -20.00%12M | --15M | ---- | -200.00%-3M | -102.94%-1M | -12.82%34M | 490.00%39M | -107.35%-10M |
Investing cash flow | -314.23%-7.21B | 286.78%3.37B | -14.96%870M | 64.21%1.02B | 142.07%623M | 63.58%-1.48B | -16.11%-4.07B | -2.52%-3.5B | -3.39%-3.42B | -4.49%-3.3B |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---- | ---- | ---87M | --0 | -51.90%76M | 155.44%158M | 0.00%-285M | 0.00%-285M | ---285M | ---- |
Net common stock issuance | --0 | -578.73%-1.5B | ---221M | --0 | ---- | ---302M | --0 | ---333M | --0 | ---- |
Increase or decrease of lease financing | 0.00%-43M | -7.50%-43M | 9.09%-40M | -15.79%-44M | 11.63%-38M | 4.44%-43M | -7.14%-45M | -2.44%-42M | 84.41%-41M | -64.38%-263M |
Cash dividends paid | 9.10%-1.42B | 4.47%-1.56B | -25.91%-1.63B | 11.53%-1.3B | 0.20%-1.47B | 16.25%-1.47B | -19.00%-1.75B | 0.14%-1.47B | 0.00%-1.48B | -1.93%-1.48B |
Net other fund-raising expenses | ---- | 17.06%-141M | -2.41%-170M | 5.14%-166M | -12.18%-175M | -13.87%-156M | 7.43%-137M | -2.07%-148M | -111.89%-145M | 61,100.00%1.22B |
Financing cash flow | 54.96%-1.46B | -50.81%-3.24B | -42.73%-2.15B | 5.99%-1.51B | 11.53%-1.6B | 18.42%-1.81B | 2.67%-2.22B | -17.21%-2.28B | -275.14%-1.95B | 60.38%-519M |
Net cash flow | ||||||||||
Beginning cash position | 10.40%25.8B | 48.20%23.37B | 5.17%15.77B | 105.00%14.99B | -2.64%7.31B | -11.22%7.51B | -10.89%8.46B | 1.58%9.49B | 6.42%9.35B | 37.00%8.78B |
Current changes in cash | -581.24%-8.16B | -75.47%1.7B | 794.05%6.91B | -89.95%773M | 4,570.93%7.69B | 81.72%-172M | -4.67%-941M | -487.50%-899M | -24.92%232M | -84.02%309M |
Effect of exchange rate changes | 44.22%1.06B | 6.68%735M | 68,800.00%689M | 109.09%1M | 56.00%-11M | -257.14%-25M | 94.78%-7M | -59.52%-134M | -132.94%-84M | -41.65%255M |
Cash adjustments other than cash changes | ---- | --1M | ---- | --1M | ---- | 0.00%-1M | 0.00%-1M | ---1M | ---- | ---- |
End cash Position | -27.51%18.7B | 10.40%25.8B | 48.20%23.37B | 5.17%15.77B | 105.00%14.99B | -2.64%7.31B | -11.22%7.51B | -10.89%8.46B | 1.58%9.49B | 6.42%9.35B |
Free cash flow | -746.65%-4.05B | -107.78%-478M | 867.75%6.14B | -111.95%-800M | 251.31%6.7B | -52.05%1.91B | 4.63%3.98B | 20.41%3.8B | 20.70%3.16B | 257.56%2.61B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |